PROCEPT BioRobotics Corporation (PRCT)

NASDAQ: PRCT · IEX Real-Time Price · USD

52.48

-1.27 (-2.36%)

At close: Apr 24, 2024, 4:00 PM

52.78

+0.30 (0.57%)

After-hours: Apr 24, 2024, 5:16 PM EDT

PROCEPT BioRobotics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	136.19	75.01	34.47	7.72	6.17
Revenue Growth (YoY)	81.55%	117.60%	346.72%	25.09%	-
Cost of Revenue	65.14	37.93	18.61	8.97	8.05
Gross Profit	71.05	37.09	15.87	-1.26	-1.89
Selling, General & Admin	131.77	88.83	51.04	30.27	28.52
Research & Development	48.45	28.98	18.99	16.28	13.15
Operating Expenses	180.22	117.81	70.03	46.55	41.67
Operating Income	-109.17	-80.72	-54.16	-47.8	-43.55
Interest Expense / Income	4	5.18	5.81	5.26	0.72
Other Expense / Income	-7.27	1.25	-0.12	-0.04	-2.3
Pretax Income	-105.9	-87.15	-59.85	-53.02	-41.98
Net Income	-105.9	-87.15	-59.85	-53.02	-41.98
Shares Outstanding (Basic)	47	44	16	4	2
Shares Outstanding (Diluted)	47	44	16	4	2
Shares Change	6.43%	169.42%	349.90%	65.90%	-
EPS (Basic)	-2.24	-1.96	-3.63	-14.47	-19.01
EPS (Diluted)	-2.24	-1.96	-3.63	-14.47	-19.01
Free Cash Flow	-133.21	-83.04	-57.93	-48.58	-51.43
Free Cash Flow Per Share	-2.82	-1.87	-3.52	-13.26	-23.29
Gross Margin	52.17%	49.44%	46.02%	-16.26%	-30.56%
Operating Margin	-80.16%	-107.61%	-157.12%	-619.44%	-705.95%
Profit Margin	-77.76%	-116.18%	-173.62%	-687.04%	-680.42%
Free Cash Flow Margin	-97.81%	-110.69%	-168.03%	-629.47%	-833.67%
EBITDA	-98.08	-77.65	-51.06	-45.06	-39.76
EBITDA Margin	-72.02%	-103.52%	-148.13%	-583.84%	-644.46%
Depreciation & Amortization	3.82	4.32	2.98	2.7	1.49
EBIT	-101.9	-81.97	-54.04	-47.76	-41.25
EBIT Margin	-74.82%	-109.27%	-156.77%	-618.87%	-668.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).